LivaNova (LIVN) Shares Soar: Market Buzz Surrounds Positive Clinical Developments
LivaNova PLC (NASDAQ: LIVN) has experienced a striking surge in its stock value during the ongoing trading session, witnessing a notable uptick of 10.35% to $55.55. This occurrence has captured the keen attention of both investors and analysts following the revelation of its favorable clinical study outcomes. LivaNova (LIVN) has today disclosed the findings from […]